Skip Navigation

JNCI Journal of the National Cancer Institute 2004 96(6):432; doi:10.1093/jnci/96.6.432
© 2004 by Oxford University Press
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Arnold, K.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Arnold, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2004 Oxford University Press

NEWS

In Brief

Katherine Arnold

The first 10% of the full text of this article appears below.

Prophylactic Mastectomy Associated with Reduced Breast Cancer Risk Among Mutation Carriers

Bilateral prophylactic mastectomy is associated with a 90% reduction in the risk of breast cancer in BRCA1 or BRCA2 mutation carriers, a new study has found.

In 1999, a group of researchers reported that bilateral prophylactic mastectomy was associated with a 90% . . . [Full Text of this Article]

Monoclonal Antibody Approved for Colorectal Cancer


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?